We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

105560:KRXKB Financial Group Inc. Analysis

Data as of 2026-05-28 - not real-time

₩149,700.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

KB Financial Group is trading at KRW 149,700, comfortably above its 200‑day SMA of 133,449 but below the 20‑day SMA of 156,480, suggesting a longer‑term bullish bias with short‑term pressure. The 14‑day RSI sits at 41, indicating modest downside momentum, while the MACD line remains negative and the histogram deepens, flagging bearish momentum on the daily chart. Volume has been trending down, and the price is near the calculated support of 146,700, with resistance at 164,200, framing a potential upside of roughly 30% as reflected in the upside/downside metric. Volatility over the past 30 days is elevated at 25.6%, yet the beta of 0.47 points to lower systematic risk relative to the market, and the Fear & Greed Index reads “Extreme Greed,” highlighting strong investor appetite.
Fundamentally, the group posted a 15.2% revenue growth year‑over‑year and maintains robust operating (60.7%) and profit margins (36.6%). The forward P/E of 7.9 is well below the industry average of 16.6, signaling an undervalued position, while the dividend yield of 2.99% with a 27% payout ratio appears sustainable. Analysts collectively rate the stock as a “strong buy” with a median target of KRW 192,500, implying a 30% upside, and the recent earnings call highlighted a 15.1% profit increase, reinforcing the growth narrative.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near strong support with upside potential
  • Strong earnings beat and 15% profit growth
  • Attractive valuation versus industry peers

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend yield of ~3%
  • Analyst consensus of strong buy and high price targets
  • Continued revenue expansion and high operating margins

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust balance sheet with manageable net debt
  • Undervalued forward P/E relative to sector
  • Diversified geographic footprint reducing concentration risk

Key Metrics & Analysis

Financial Health

Revenue Growth15.20%
Profit Margin36.58%
P/E Ratio7.9
ROE9.99%
ROA0.76%
Op. Cash Flow₩-26548566491136
Industry P/E16.6

Technical Analysis

TrendBullish
RSI41.2
Support₩146,700.00
Resistance₩164,200.00
MA 20₩156,480.00
MA 50₩154,598.00
MA 200₩133,449.00
MACDBearish
VolumeDecreasing
Fear & Greed Index92.34

Valuation

Target Price₩195,750.00
Upside/Downside30.76%
GradeUndervalued
TypeBlend
Dividend Yield2.99%

Risk Assessment

Beta0.47
Volatility25.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.